Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03888807 · ClinicalTrials.gov registry record · Phase 4
Biofreeze® vs. a Placebo on Knee Osteoarthritis Walking Gait Characteristics and Pain
A Phase 4 study, sponsored by Sport and Spine Rehab Clinical Research Foundation.
- Terminated
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT03888807 is a Phase 4 study that was terminated before completion, run by Sport and Spine Rehab Clinical Research Foundation. The registered enrollment target is 6 participants.
The verdict
NCT03888807, a Phase 4 study, was terminated before completion, sponsored by Sport and Spine Rehab Clinical Research Foundation.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of Biofreeze® versus a placebo on walking gait characteristics and pain during walking in individuals with bilateral knee osteoarthritis (OA).
Interventions
- DRUG Placebo
- DRUG Biofreeze
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2024-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03888807
The ClinicalTrials.gov registry entry for NCT03888807 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sport and Spine Rehab Clinical Research Foundation, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03888807 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03888807 about?
NCT03888807 is a clinical study titled "Biofreeze® vs. a Placebo on Knee Osteoarthritis Walking Gait Characteristics and Pain". The purpose of this study is to determine the effect of Biofreeze® versus a placebo on walking gait characteristics and pain during walking in individuals with bilateral knee osteoarthritis (OA).
What is the current status of trial NCT03888807?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2018-03-01. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT03888807?
The interventions under investigation include: Placebo (DRUG), Biofreeze (DRUG).
Who is sponsoring clinical trial NCT03888807?
This trial is sponsored by Sport and Spine Rehab Clinical Research Foundation, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.